The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Clinical pharmacokinetics; concepts and applications
(1989) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(89)90348-0 · Cited by 2,223
Applied pharmacokinetics : principles of therapeutic drug monitoring
Evans, W. E., Schentag, J. J., & Jusko, W. J. (1992) · Medical Entomology and Zoology · Cited by 1,044
Rodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776
Self-citationPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
Poulin, P., & Theil, F. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<16::aid-jps3>3.0.co;2-e · Cited by 424
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
Jusko, W. J., & Gretch, M. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537608995839 · Cited by 372
Poulin, P., & Theil, F.-P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10128 · Cited by 303
Berezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs
Poulin, P., Schoenlein, K., & Theil, F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<436::aid-jps1002>3.0.co;2-p · Cited by 213
Clinical Pharmacokinetics: Concepts and applications.
Bryson, S. M. (1983) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1983.tb00901.x · Cited by 177
Poulin, P., & Krishnan, K. (1995) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399509532021 · Cited by 159
Tsuji, A., Yoshikawa, T., NISHIDE, K., Minami, H., Kimura, M., Nakashima, E., Terasaki, T., Miyamoto, E., Nightingale, C. H., & Yamana, T. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721103 · Cited by 145
Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125
Kawai, R., Lemaire, M., Steimer, J., Bruelisauer, A., Niederberger, W., & Rowland, M. (1994) · Journal of pharmacokinetics and biopharmaceutics · doi:10.1007/bf02353860 · Cited by 133
Self-citationRodgers, T., Leahy, D. E., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20323 · Cited by 131
Self-citationPoulin, P., & Krishnan, K. (1995) · Human & Experimental Toxicology · doi:10.1177/096032719501400307 · Cited by 125
Computational prediction of the plasma protein‐binding percent of diverse pharmaceutical compounds
Yamazaki, K., & Kanaoka, M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20059 · Cited by 112
Igari, Y., Sugiyama, Y., Sawada, Y., Iga, T., & Hanano, M. (1983) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059058 · Cited by 105
The phospholipid composition of plasma in various mammalian species
Nelson, G. J. (1967) · Lipids · doi:10.1007/bf02532119 · Cited by 98
Björkman, S. E. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702320402080 · Cited by 97
Ebling, W. F., Wada, D. R., & Stanski, D. R. (1994) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353622 · Cited by 94
Sawada, Y., Hanano, M., Sugiyama, Y., & Iga, T. (1985) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059331 · Cited by 87
Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences
Fichtl, B., von Nieciecki, A., & Walter, K. (1991) · Advances in Drug Research · doi:10.1016/b978-0-12-013320-8.50006-x · Cited by 80
Lin, J., Sugiyama, Y., Awazu, S., & Hanano, M. (1982) · Journal of pharmacokinetics and biopharmaceutics · doi:10.1007/bf01062545 · Cited by 79
Regulation of organic anion and drug transporters of the sinusoidal membrane
Kullak-Ublick, G. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80054-3 · Cited by 72
Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man
Pierson, R. N., Price, D. C., Wang, J., & Jain, R. K. (1978) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1978.235.3.f254 · Cited by 71
Worboys, P. D., Bradbury, A., & Houston, J. B. (1997) · PubMed · Cited by 71
Björkman, S. E., Stanski, D. R., Verotta, D., & Harashima, H. (1990) · Anesthesiology · doi:10.1097/00000542-199005000-00017 · Cited by 66
Physiologically Based Pharmacokinetic Model for Digoxin Distribution and Elimination in the Rat
Harrison, L. I., & Gibaldi, M. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660822 · Cited by 66
Dose-Dependent Pharmacokinetics of Cyclosporin A in Rats: Events in Tissues
Tanaka, C., Kawai, R., & Rowland, M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15104-5 · Cited by 64
Self-citationOoie, T., Terasaki, T., Suzuki, H., & Sugiyama, Y. (1997) · PubMed · Cited by 61
Zhao, Y., Jona, J. A., Chow, D. T., Rong, H., Semin, D. J., Xia, X., Zanon, R. L., Spancake, C., & Maliski, E. G. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.749 · Cited by 57
Takasawa, K., Terasaki, T., Suzuki, H. I., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36945-9 · Cited by 53
Okezaki, E., Terasaki, T., Nakamura, M., et al. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07057-6 · Cited by 44
Prediction of drug distribution in vivo on the basis of in vitro binding data
Schuhmann, G., Fichtl, B., & Kurz, H. (1987) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510080109 · Cited by 40
Gueorguieva, I., Nestorov, I. A., Murby, S., Gisbert, S., Collins, B., Dickens, K., Duffy, J. C., Hussain, Z., & Rowland, M. (2004) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/b:jopa.0000042737.14033.c6 · Cited by 33
Self-citationRelationships among petroleum refining, water and sediment contamination, and fish health
Kuehn, R. L., Berlin, K. D., Hawkins, W. E., & Ostrander, G. K. (1995) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399509532020 · Cited by 28
Ballard, P. G., Leahy, D. E., & Rowland, M. (2003) · Pharmaceutical Research · doi:10.1023/a:1023912318133 · Cited by 21
Self-citationPhysiologically Based Pharmacokinetic Models of 2′,3′-Dideoxyinosine
Kang, H.-J. K., Wientjes, M. G., & Au, J. L. ‐. (1997) · Pharmaceutical Research · doi:10.1023/a:1012002206007 · Cited by 20
Tsuji, A., Terasaki, T., IMAEDA, N., NISHIDE, K., & Tamai, I. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780705 · Cited by 16
Acceleration of the elimination of tenoxicam by cholestyramine in the dog.
Guentert, T. W., Schmitt, M., & Defoin, R. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25033-9 · Cited by 15
Distribution of ceftazidime in rat tissues
Granero, L. M., Chesa-Jiménez, J., Torres‐Molina, F., & Peris, J. (1998) · Biopharmaceutics & Drug Disposition · Cited by 14
Prediction of ftorafur disposition in rats and man by a physiologically based pharmacokinetic model
YOKO, S., YOSHIJI, T., YASUFUMI, S., MANABU, H., TERUYOSHI, M., & YUKIHIKO, U. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90174-7 · Cited by 7
Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
Brée, F., Houin, G., Barré, J., Riant, P., & Tillement, J. P. (1989) · PubMed · Cited by 6
Research works printed but not linked: 18
- Chen, 2004, Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography, J Chromatogr B, 809, 137, 10.1016/j.jchromb.2004.06.012 · doi:10.1016/j.jchromb.2004.06.012
- Aubry, 1995, Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography, Comp Biochem Physiol, 112C, 257
- Rahman, 1993, Studies of interaction of caprofen and its enantiomers with albumin I: mechanism of binding studied by dialysis and spectroscopic methods, Biochem Pharmacol, 46, 1721, 10.1016/0006-2952(93)90576-I · doi:10.1016/0006-2952(93)90576-i
- Bjorkman, 1996, Determination of the steady state distribution of midazolam in the rat, J Pharm Sci, 85, 887, 10.1021/js960113+ · doi:10.1021/js960113+
- Lee, 1988, Kinetics and mechanisms of etodolac degradation in aqueous solutions, J Pharm Sci, 77, 81, 10.1002/jps.2600770116 · doi:10.1002/jps.2600770116
- Brooks, 1990, The pharmacokinetics of etodolac enantiomers in the rat: lack of pharmacokinetic interaction between enantiomers, Drug Metab Dispos, 18, 471
- Chatton, 1990, Salictclic acid permeability properties of the rabbit cortical collecting duct, Am J Physiol, 259, F613
- Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, J Pharm Sci, 12, 500
- Kwon, 1987, Physiological pharmacokinetic model for the distribution and elimination of tenoxicam, Int J Pharmaceut, 37, 219, 10.1016/0378-5173(87)90032-9 · doi:10.1016/0378-5173(87)90032-9
- Kessel, 2001, Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer, Biophys J, 80, 2536, 10.1016/S0006-3495(01)76225-X · doi:10.1016/s0006-3495(01)76225-x
- Naber, 2003, Antibiotic therapy-rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue, Andrologia, 35, 331, 10.1111/j.1439-0272.2003.tb00868.x · doi:10.1111/j.1439-0272.2003.tb00868.x
- Brooks, 1991, Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding and in vitro metabolism, J Pharm Sci, 80, 1058, 10.1002/jps.2600801112 · doi:10.1002/jps.2600801112
- Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, Drug Metab Dispos, 12, 500
- Funakoshi, 2005, Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and -methyldigoxin in rats, J Pharm Sci, 94, 1196, 10.1002/jps.20346 · doi:10.1002/jps.20346
- Olanoff, 1979, Controlled release of tetracycline II: development of an in vivo flow-limited pharmacokinetic model, J Pharm Sci, 68, 1151, 10.1002/jps.2600680925 · doi:10.1002/jps.2600680925
- Yu, 1995, Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity limited distribution, Pharm Res, 12, 421, 10.1023/A:1016264821127 · doi:10.1023/a:1016264821127
- Olanoff, 1980, Controlled release of tetracycline III: a physiological pharmacokinetic model of the pregnant rat, J Pharmacokin Biopharm, 8, 599, 10.1007/BF01060056 · doi:10.1007/bf01060056
- Funakoshi, 2003, Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and -methyldigoxin in rats, J Pharm Sci, 92, 1455, 10.1002/jps.10416 · doi:10.1002/jps.10416
Cited by
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Self-citationCoexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Root Uptake of Pharmaceuticals and Personal Care Product Ingredients
Miller, E. L., Nason, S. L., Karthikeyan, K. G., & Pedersen, J. A. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.5b01546 · Cited by 524
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Metadata
- Authors
- Rodgers, T., & Rowland, M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 95
- Issue
- 6
- Pages
- 1238-1257
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2113830209
- Cited by
- 946
- References
- 45
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.